Amyloid-lowering treatment in Alzheimer's disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F24%3A10487520" target="_blank" >RIV/00064203:_____/24:10487520 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/24:10487520
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=dBcgGtHdQE" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=dBcgGtHdQE</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S0140-6736(24)02510-8" target="_blank" >10.1016/S0140-6736(24)02510-8</a>
Alternative languages
Result language
angličtina
Original language name
Amyloid-lowering treatment in Alzheimer's disease
Original language description
In short, we echo the Editorial in stating that the development of the first disease-modifying treatment for Alzheimer's disease is a tremendous moment for science and society. Europe and European patients should not fall behind.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The Lancet
ISSN
0140-6736
e-ISSN
1474-547X
Volume of the periodical
404
Issue of the periodical within the volume
10468
Country of publishing house
GB - UNITED KINGDOM
Number of pages
2
Pages from-to
2161-2162
UT code for WoS article
001388685900001
EID of the result in the Scopus database
2-s2.0-85210073822